1-16 of 16
Jacob J. Chabon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA Dynamics as Early Outcome Predictors for Lisocabtagene Maraleucel as Second-Line Therapy for Large B-Cell Lymphoma from the Phase 3 TRANSFORM Study

Lara Stepan, Sahar Ansari, Abood Okal, Justine Dell'Aringa, Ethan Thompson, Alessandro Crotta, Victor A Chow, Jeremy S. Abramson, Manali Kamdar, Jacob J. Chabon, Gregory Hogan, David M. Kurtz, Ash A. Alizadeh, Leanne Peiser
Journal: Blood
Blood (2023) 142 (Supplement 1): 225.
https://doi.org/10.1182/blood-2023-181007
Published: 2023
Journal Articles

Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas

Ákos Nagy, Bence Bátai, Gregory Hogan, Jacob J. Chabon, Mikayla Troke, Lance Riley, Andre Schultz, Sandra Close, Maximilian Diehn, Donát Alpár, Botond Timár, Ash A. Alizadeh, David M. Kurtz, Csaba Bödör
Journal: Blood
Blood (2023) 142 (Supplement 1): 1626.
https://doi.org/10.1182/blood-2023-189824
Published: 2023
Journal Articles

Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy

Jordan Goldstein, Won Seog Kim, Sang Eun Yoon, Seok Jin Kim, Mark Roschewski, Jason Westin, Ryan C Lynch, Stefan K. Alig, Sandra Close, Jacob J. Chabon, Davide Rossi, Wyndham H Wilson, Maximilian Diehn, Ash A. Alizadeh, David M. Kurtz
Journal: Blood
Blood (2023) 142 (Supplement 1): 187.
https://doi.org/10.1182/blood-2023-187759
Published: 2023
Journal Articles

Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

David M. Kurtz, Gregory Hogan, Andre Schultz, Jacob J. Chabon, Ash A. Alizadeh, Karin Havenith, Sara Samari, Tim Kopotsha, Luqiang Wang, Yajuan Qin, Ying Wang, Serafino Pantano
Journal: Blood
Blood (2023) 142 (Supplement 1): 3133.
https://doi.org/10.1182/blood-2023-179977
Published: 2023
Journal Articles

Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study

Brian J. Sworder, Sang Eun Yoon, Seok Jin Kim, Andre Schultz, Gregory Hogan, Sandra Close, Jacob J. Chabon, Maximilian Diehn, David M. Kurtz, Ash A. Alizadeh, Won Seog Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 69.
https://doi.org/10.1182/blood-2023-187650
Published: 2023
Journal Articles

Ultrasensitive Circulating Tumor DNA (ctDNA) Dynamics after Autologous CD30.CAR-T Cell Therapy for Relapsed or Refractory (r/r) Classical Hodgkin Lymphoma (CHARIOT Trial)

David M. Kurtz, Sairah Ahmed, Cheuk Ka Tong, Matthew Mei, Cliff Ding, Ian W. Flinn, Peter A. Riedell, Gregory J. Hogan, Andre Schultz, Jacob J. Chabon, Helen E. Heslop, Aung Myo, Ash A. Alizadeh, Ivan D. Horak
Journal: Blood
Blood (2022) 140 (Supplement 1): 2378–2380.
https://doi.org/10.1182/blood-2022-162150
Published: 2022
Journal Articles

Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP

David M. Kurtz, Gregory J. Hogan, Andre Schultz, Katerina Kopeckova, Christian Kuffer, Derek Blair, Steve Wagner, Sandra Close, Maximilian Diehn, Jacob J. Chabon, Ash A. Alizadeh, Jason Westin
Journal: Blood
Blood (2022) 140 (Supplement 1): 3498–3499.
https://doi.org/10.1182/blood-2022-168378
Published: 2022
Journal Articles

MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials & Implications for Clinical Trial Design

Mark Roschewski, David M. Kurtz, Jason Westin, Ryan C. Lynch, Charles Macaulay, Christian Kuffer, Gregory J. Hogan, Sandra Close, Jacob J. Chabon, Davide Rossi, Maximilian Diehn, Ash A. Alizadeh, Andre Schultz
Journal: Blood
Blood (2022) 140 (Supplement 1): 785–786.
https://doi.org/10.1182/blood-2022-167936
Published: 2022
Journal Articles

Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib

Mark Roschewski, James D. Phelan, Stefania Pittaluga, Christopher Melani, Rahul Lakhotia, Jacob J. Chabon, Jagan R. Muppidi, Kathryn A. Lurain, Jillian Simard, Amynah Pradhan, Amy Hillsman, Madeline Rilko, Seth M. Steinberg, George W. Wright, Da Wei Huang, Yandan Yang, Michail S. Lionakis, Alexander Bagaev, Ekaterina Postovalova, Mark Meerson, Olga Kudryashova, Nikita Kotlov, Nathan H. Fowler, David M. Kurtz, Ash A. Alizadeh, Elaine S. Jaffe, Louis M. Staudt, Wyndham H. Wilson
Journal: Blood
Blood (2021) 138 (Supplement 1): 524.
https://doi.org/10.1182/blood-2021-145228
Published: 2021
Journal Articles

Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy

Brian Sworder, MD PhD, David M. Kurtz, MD PhD, Charles Macaulay, MSc, BA, Matthew J. Frank, MD PhD, Stefan Alig, MD, Andrea Garofalo, BS, BA, Bita Sahaf, PhD, Mohammad Shahrokh Esfahani, Jay Y. Spiegel, MDFRCPC, Jean Oak, MD PhD, Sara Beygi, MD, Michael C. Jin, BS, Jacob J Chabon, Michael S. Khodadoust, MD PhD, Robbie G. Majzner, MD, Crystal L. Mackall, MD, Maximilian Diehn, MD PhD, David B Miklos, MD PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 550.
https://doi.org/10.1182/blood-2019-129015
Published: 2019
Journal Articles

Determinants of Circulating Tumor DNA Levels across Lymphoma Histologic Subtypes

Joseph G Schroers-Martin, MD, David M. Kurtz, MD, Joanne Soo, BS, Michael Jin, Florian Scherer, MD, Alexander Craig, MPhil, Jacob J Chabon, Chih Long Liu, PhD, Henning Stehr, PhD, Ulrich Duehrsen, MD, Andreas Hüttmann, MD, Anne Ségolène Cottereau, Michel Meignan, Olivier Casasnovas, MD, Jason R. Westin, MD, Gianluca Gaidano, MD PhD, Davide Rossi, MD PhD, Ranjana H. Advani, MD, Mark Roschewski, MD, Wyndham H. Wilson, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4018.
https://doi.org/10.1182/blood.V130.Suppl_1.4018.4018
Published: 2017
Journal Articles

Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma

David M. Kurtz, MD, Florian Scherer, MD, Michael Jin, Joanne Soo, BS, Alexander Craig, MPhil, Mohammad S Esfahani, PhD, Jacob J Chabon, Henning Stehr, PhD, Chih Long Liu, PhD, Robert Tibshirani, Lauren S. Maeda, Neel K. Gupta, MD, Michael Khodadoust, MD PhD, Ranjana H. Advani, MD, Ronald Levy, MD, Aaron Newman, Jason R. Westin, MD, Gianluca Gaidano, MD PhD, Davide Rossi, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 826.
https://doi.org/10.1182/blood.V130.Suppl_1.826.826
Published: 2017
Journal Articles

Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study

David M. Kurtz, MD, Michael Jin, Joanne Soo, BS, Florian Scherer, MD, Alexander Craig, MPhil, Jacob J Chabon, Joseph G Schroers-Martin, MD, Chih Long Liu, PhD, Henning Stehr, PhD, Christine Schmitz, MD, Ulrich Duehrsen, MD, Andreas Hüttmann, MD, Anne Ségolène Cottereau, Michel Meignan, Olivier Casasnovas, MD, Jason R. Westin, MD, Gianluca Gaidano, MD PhD, Davide Rossi, MD PhD, Mark Roschewski, MD, Wyndham H. Wilson, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 310.
https://doi.org/10.1182/blood.V130.Suppl_1.310.310
Published: 2017
Journal Articles

Noninvasive Detection of BCL2 , BCL6 , and MYC Translocations in Diffuse Large B-Cell Lymphoma

David M. Kurtz, MD, Florian Scherer, MD, Aaron M Newman, PhD, Alexander Craig, MPhil, Michael Jin, Henning Stehr, PhD, Jacob J. Chabon, Mohammad Esfahani, Chih Long Liu, Li Zhou, Cynthia Glover, Brendan C. Visser, MD, George Poultsides, MD, Ranjana H Advani, MD, Lauren S Maeda, MD, Neel K. Gupta, MD, Ronald Levy, MD, Robert S. Ohgami, MD PhD, R Eric Davis, MD, Christian A. Kunder, MD PhD, Jason R. Westin, MD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2930.
https://doi.org/10.1182/blood.V128.22.2930.2930
Published: 2016
Journal Articles

Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma

David M. Kurtz, MD, Florian Scherer, MD, Aaron M. Newman, PhD, Alexander F. Lovejoy, PhD, Daniel M. Klass, PhD, Jacob J. Chabon, Sanjiv Gambhir, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2015) 126 (23): 130.
https://doi.org/10.1182/blood.V126.23.130.130
Published: 2015
Journal Articles

Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma

Florian Scherer, MD, David M. Kurtz, MD, Aaron M. Newman, PhD, Henning Stehr, PhD, Chih Long Liu, PhD, Li Zhou, Alexander F.M. Craig, Jacob J. Chabon, Alexander F. Lovejoy, PhD, Daniel M. Klass, PhD, Cynthia Glover, Robert S. Ohgami, MDPhD, Christian A. Kunder, MD PhD, Brendan C. Visser, MD, George Poultsides, MD, Ronald Levy, MD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2015) 126 (23): 114.
https://doi.org/10.1182/blood.V126.23.114.114
Published: 2015